Coherus BioSciences Outlines ‘Very Different Approach’ And Raises Another US$75m To Launch Udenyca

 
• By Dean Rudge
  
TrayOfMoney
A US$75m cash injection has aided Coherus' launch strategy • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products